CPT® Code 91310

Deleted

1. Indications

The CPT® Code 91310 is indicated for the administration of the COVID-19 vaccine in specific circumstances. The following conditions outline the indications for this vaccine:

• Booster Dose This vaccine is specifically indicated for use as a booster dose in adult patients aged 18 years and older who have completed a primary series of any approved COVID-19 vaccine, including those from Pfizer, Moderna, or Johnson & Johnson.
• Protection Against SARS-CoV-2 The vaccine is intended to provide protection against the SARS-CoV-2 virus, which can lead to COVID-19, a potentially severe and life-threatening disease.

2. Procedure

The administration of the COVID-19 vaccine under CPT® Code 91310 involves several procedural steps that ensure the vaccine is delivered safely and effectively. The following steps outline the procedure:

• Step 1: Patient Assessment Prior to administration, a thorough assessment of the patient is conducted to confirm eligibility for the booster dose. This includes verifying that the patient is at least 18 years old and has completed the primary vaccination series with an approved COVID-19 vaccine.
• Step 2: Preparation of Vaccine The vaccine is prepared according to the manufacturer's guidelines. This includes ensuring that the vaccine is at the appropriate temperature and that the correct dosage of 5 mcg in a 0.5 mL volume is drawn into a sterile syringe.
• Step 3: Administration The vaccine is administered intramuscularly, typically in the deltoid muscle of the upper arm. Proper injection techniques are followed to minimize discomfort and ensure effective delivery of the vaccine.
• Step 4: Post-Administration Monitoring After the vaccine is administered, the patient is monitored for a short period to observe for any immediate adverse reactions. This is a standard practice to ensure patient safety following vaccination.

3. Post-Procedure

Following the administration of the COVID-19 vaccine under CPT® Code 91310, patients are advised on post-procedure care and expected outcomes. It is common for patients to experience mild side effects, such as soreness at the injection site, fatigue, or low-grade fever, which typically resolve within a few days. Patients should be informed about the importance of completing the vaccination series and the role of the booster in enhancing immunity against COVID-19. Additionally, they should be advised to report any unusual or severe reactions to their healthcare provider. Documentation of the vaccine administration, including the date, lot number, and site of injection, is essential for maintaining accurate medical records and ensuring compliance with vaccination tracking requirements.